ScruplesResearch OÜ

Active Registry code 16750246 OÜ Tallinn Registered 1 Jun 2023
Compare

ScruplesResearch OÜ is a OÜ based in Tallinn, registry code 16750246, status: active. Main activity: Research and experimental development on social sciences and humanities. According to EMTA, turnover for Q3 2026 was €14 532 with employees.

Turnover
14 532 €
↓ 58.4% vs Q2 2026
State taxes
—
Labour taxes
—
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Turnover · Q3 2026 14 532 €
    industry median 14 442 € · companies in the industry: 318
  • Revenue · 2024 281 577 €
    industry median 0 € · companies in the industry: 1 053
  • Net profit margin · 2024 7.5 %
    industry median 15.8 % · companies in the industry: 617

Taxes and turnover

Q4 2023 – Q3 2026
Turnover, € thousand Q3 2026: 14 532 € · −58.4% vs Q2 2026 · industry median 14 442 € · above 50% of the industry
050100150Q4 2023 Company: 64 511 € Industry median: 15 375 €Q4·23Q1 2024 Company: 113 103 € Industry median: 14 938 €Q2 2024 Company: 70 964 € Industry median: 14 999 €Q2·24Q3 2024 Company: 46 387 € Industry median: 11 985 €Q4 2024 Company: 71 407 € Industry median: 16 752 €Q4·24Q1 2025 Company: 137 019 € Industry median: 15 203 €Q2 2025 Company: 36 500 € Industry median: 14 420 €Q2·25Q3 2025 Company: 40 311 € Industry median: 13 763 €Q4 2025 Company: 31 130 € Industry median: 13 976 €Q4·25Q1 2026 Company: 28 174 € Industry median: 14 268 €Q2 2026 Company: 34 914 € Industry median: 14 545 €Q2·26Q3 2026 Company: 14 532 € Industry median: 14 442 €Q3·26050100150Q4 2024 Company: 71 407 € Industry median: 16 752 €Q1 2025 Company: 137 019 € Industry median: 15 203 €Q1·25Q2 2025 Company: 36 500 € Industry median: 14 420 €Q3 2025 Company: 40 311 € Industry median: 13 763 €Q3·25Q4 2025 Company: 31 130 € Industry median: 13 976 €Q1 2026 Company: 28 174 € Industry median: 14 268 €Q1·26Q2 2026 Company: 34 914 € Industry median: 14 545 €Q3 2026 Company: 14 532 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q4 2025: 214 € · −95.2% vs Q3 2025
02 0004 0006 000Q4 2023 Company: 1 879 €Q4·23Q1 2024 Company: —Q2 2024 Company: —Q2·24Q3 2024 Company: 5 499 €Q4 2024 Company: —Q4·24Q1 2025 Company: 3 089 €Q2 2025 Company: 848 €Q2·25Q3 2025 Company: 4 458 €Q4 2025 Company: 214 €Q4·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·2601 0002 0003 0004 0005 000Q4 2024 Company: —Q1 2025 Company: 3 089 €Q1·25Q2 2025 Company: 848 €Q3 2025 Company: 4 458 €Q3·25Q4 2025 Company: 214 €Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 14 532 — — —
Q2 2026 34 914 — — —
Q1 2026 28 174 — — —
Q4 2025 31 130 214 — —
Q3 2025 40 311 4 458 — —
Q2 2025 36 500 848 — —
Q1 2025 137 019 3 089 — —
Q4 2024 71 407 — — —
Q3 2024 46 387 5 499 — —
Q2 2024 70 964 — — —
Q1 2024 113 103 — — —
Q4 2023 64 511 1 879 — —
Q3 2023 5 997 1 199 — —

Financials by year

2023 – 2024
Revenue, € thousand 2024: 281 577 € · +121.2% vs 2023 · industry median 0 € · above 98% of the industry
01002003002023 Company: 127 294 € Industry median: 76 €20232024 Company: 281 577 € Industry median: 0 €202401002003002023 Company: 127 294 € Industry median: 76 €2024 Company: 281 577 € Industry median: 0 €2024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2024: 21 240 € · −29.5% vs 2023 · industry median 0 € · above 88% of the industry
010 00020 00030 00040 0002023 Company: 30 114 € Industry median: 0 €20232024 Company: 21 240 € Industry median: 0 €2024010 00020 00030 00040 0002023 Company: 30 114 € Industry median: 0 €2024 Company: 21 240 € Industry median: 0 €2024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2024: 7.5 % · −16.1 pp vs the year before · industry median 15.8 % · above 42% of the industry
05101520252023 Company: 23.7 % Industry median: 16.8 %20232024 Company: 7.5 % Industry median: 15.8 %202405101520252023 Company: 23.7 % Industry median: 16.8 %2024 Company: 7.5 % Industry median: 15.8 %2024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2024: 80 500 € · +85.4% vs 2023
020 00040 00060 00080 000100 0002023 Company: 43 422 €20232024 Company: 80 500 €2024020 00040 00060 00080 000100 0002023 Company: 43 422 €2024 Company: 80 500 €2024
Equity, € 2024: 61 147 € · +67.9% vs 2023
020 00040 00060 00080 0002023 Company: 36 415 €20232024 Company: 61 147 €2024020 00040 00060 00080 0002023 Company: 36 415 €2024 Company: 61 147 €2024
Employees 2024: 0 · −100.0% vs 2023 · industry median 1 · above 2% of the industry
01232023 Company: 3 Industry median: 120232024 Company: 0 Industry median: 1202401232023 Company: 3 Industry median: 12024 Company: 0 Industry median: 12024
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2024 281 577 21 240 0 80 500 61 147 0
2023 127 294 30 114 12 000 43 422 36 415 3

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2024

Net profit margin
7.5 %
Net profit / revenue
Return on equity (ROE)
34.7 %
Net profit / equity
Return on assets (ROA)
26.4 %
Net profit / assets
Equity ratio
76.0 %
Equity / assets
Debt ratio
24.0 %
Liabilities / assets
Current ratio
4.13
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2024 1 Jan 2024 – 31 Dec 2024 22 Jul 2025 Company’s own e-Äriregister
2023 1 Jun 2023 – 31 Dec 2023 30 Jun 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 72201Research and experimental development on social sciences and humanities Main

Rulings 7

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50229795 / 7
3 Jun 2025
 Amendment entry In force
3 Jun 2025
 PDF
Ä 50229795 / 6
26 Mar 2025
 Amendment entry In force
26 Mar 2025
 PDF
Ä 50229795 / 5
24 Mar 2025
 Amendment entry In force
24 Mar 2025
 PDF
Ä 50229795 / 4
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50229795 / 3
27 Jul 2023
 Amendment entry In force
27 Jul 2023
 PDF
Ä 50229795 / 2
27 Jul 2023
 Amendment entry In force
27 Jul 2023
 PDF
Ä 50229795
1 Jun 2023
 First entry In force
1 Jun 2023
 PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data